Insider · CIK 0002086823
Robert Ephron
Files at TAOX (TAO Synergies Inc.). First filing -, latest -.
In brief
Robert Ephron files SEC Form 4 as director at TAOX (TAO Synergies Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Ephron has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 18, 2026 | TAOX TAO Synergies Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | May 19, 2026 |
| Apr 7, 2026 | TAOX TAO Synergies Inc. | AGrant or award Stock Option (Right to Buy)derivative | +800 | $0.00 | $0 | 800 | Apr 8, 2026 |
| Oct 17, 2025 | TAOX TAO Synergies Inc. | AGrant or award Common Stock, par value $0.0001 per share | +7,500 | $0.00 | $0 | 7,500 | Oct 17, 2025 |
| Oct 17, 2025 | TAOX TAO Synergies Inc. | FTax withholding Common Stock, par value $0.0001 per share | -3,000 | $7.23 | $22k | 4,500 | Oct 17, 2025 |
Questions about Robert Ephron
Answered from the filings on this page, as of the latest one.
Is Robert Ephron buying or selling?
Robert Ephron has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Ephron's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Ephron has 0.
Where does Robert Ephron file Form 4?
Robert Ephron has filed Form 4 at TAOX (TAO Synergies Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.